Buyers of a bacterial meningitis vaccine made by Sanofi-Pasteur will share in a $61.5 million settlement of an antitrust class action following Friday’s ruling by a U.S. judge granting final approval to the deal.

U.S. District Judge John Michael Vazquez also approved $20.5 million in legal fees, $7.2 million in costs, and service awards of $100,000 each to three medical practices that served as class representatives. All of the roughly 30,000 class members who submit claim forms will share in the portion of the settlement fund that remains after legal fees, costs and service awards are paid.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]